Holen Sie sich die Stockscreener-App
190.20
1.84%
-3.56
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ILMN?
Forum
Prognose
Aktiensplit
Illumina Inc Aktie (ILMN) Neueste Nachrichten
Illumina Inc. stock underperforms Friday when compared to competitors - MarketWatch
Illumina builds out C-suite with 2 new execs - MedTech Dive
Illumina Inc (ILMN) Stock Up 3.2% but GF Value Says Overvalued -- GF Score: 72/100 - GuruFocus
Illumina sets July 30 call on second-quarter 2026 results - Stock Titan
Illumina to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026 - marketscreener.com
Illumina appoints Michael Sullivan Chief Commercial Officer and Julie Coletti Chief Legal Officer - Morgan County Citizen
Genomics Giant Illumina Taps Veteran Life Sciences Lawyer - Law.com
Illumina (ILMN) Is Up 6.87% in One Week: What You Should Know - Yahoo Finance
Illumina stock steadies as investors weigh core sequencing demand and regulatory overhang - ad-hoc-news.de
Illumina: While You Chased AI, This Healthcare Stock Built A $30B Moat (NASDAQ:ILMN) - Seeking Alpha
Illumina Stock Gains 43.7% in 2026: What's Powering the Rally? - Yahoo Finance
Illumina, Inc. Announces Management Appointments - marketscreener.com
Illumina Appoints Michael Sullivan and Julie Coletti to Executive Leadership Team - citybiz
Illumina appoints new commercial and legal officers - Investing.com
Illumina taps two senior leaders to steer sales and legal strategy - Stock Titan
Illumina Inc. focuses on genomics growth as a leading Nasdaq-listed life sciences company - ad-hoc-news.de
Align's Julie Coletti to Leave as Chief Legal and Regulatory Officer for Illumina - TradingView
Illumina (ILMN) Stock May Be 27% Undervalued Following Strong Q1 Results - Yahoo Finance
Illumina Inc. stock outperforms competitors despite losses on the day - MarketWatch
Illumina (ILMN) Jumps On Earnings And Guidance As Valuation Questions Remain - Yahoo Finance
Illumina (ILMN) Is Up 9.1% After Raising EPS Outlook On Revenue Beat Has The Bull Case Changed? - Yahoo Finance
Bifrost Biosystems Pens Agreement with Illumina for Supply of Sequencing Chemistry for Optical Pooled Screening Platform - BioSpace
Illumina, Inc. (ILMN) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Illumina (ILMN) Lifts Full Year EPS Outlook After Revenue Beat - Yahoo Finance
David P. King elected to Illumina's Board of Directors - AOL.com
Price to earnings forward of Illumina, Inc. – EUROTLX:4ILMN - TradingView
Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Illumina Inc focuses on sequencing platform innovation as investors weigh long-term growth prospects - ad-hoc-news.de
Life Sciences Tools & Services Stocks Q1 Results: Benchmarking Illumina (NASDAQ:ILMN) - Yahoo Finance
Illumina stock stays tied to its sequencing business. Investors watch the next filing. - Ad-hoc-news.de
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Illumina Looks To Duck DNA Rival's Renewed Antitrust Case - Law360
Weekly Recap: Axelios challenges Illumina and Guggenheim lifts ILMN target to $200 - TradingView
Illumina, Inc. (ILMN) Stock Analysis: Navigating Potential Downsides Amidst 33.82% ROE - DirectorsTalk Interviews
Environmental DNA Market Set to Surge to USD 5.61 Billion by 2031 with 10.2% CAGR - GlobeNewswire Inc.
iSeq 100 System from Illumina Inc.compact benchtop sequencer targets cost-conscious US labs - Ad-hoc-news.de
Is Illumina (ILMN) Quietly Recasting Its Clinical Genomics Strategy With Eli Lilly’s R&D Chief on Board? - simplywall.st
Illumina Inc. focuses on sequencing technology leadership as investors watch long-term growth driver - Ad-hoc-news.de
Illumina SVP Jakob Wedel Christensen sells $97,328 in stock - Investing.com
Illumina Inc. focuses on sequencing technology as investors assess long-term growth - Ad-hoc-news.de
Should You Continue to Hold ILMN Stock in Your Portfolio? - Yahoo Finance
Price to sales forward of Illumina, Inc. – NASDAQ:ILMN - TradingView
Price to book forward of Illumina, Inc. – NASDAQ:ILMN - TradingView
Enterprise value to revenue forward of Illumina, Inc. – NASDAQ:ILMN - TradingView
Enterprise value to EBITDA forward of Illumina, Inc. – NASDAQ:ILMN - TradingView
Enterprise value to EBIT forward of Illumina, Inc. – NASDAQ:ILMN - TradingView
Form 4 Illumina Inc For: 2 July By Investing.com - Investing.com Nigeria
Illumina (ILMN) director takes 2026 board fees entirely in stock - Stock Titan
[Form 4] ILLUMINA, INC. Insider Trading Activity - Stock Titan
ILMNIllumina Inc Volatility & Greeks - Finviz
Loomis Sayles Growth Fund's Illumina Inc(ILMN) Holding History - GuruFocus
Illumina Inc (ILMN) Stock Up 4.6% but GF Value Says Overvalued -- GF Score: 76/100 - GuruFocus
Illumina (ILMN) Gets Bernstein’s Market Perform Rating Amid NovaSeq X Recovery - Insider Monkey
Illumina stock hits 52-week high at 182.98 USD - Investing.com
Illumina stock hits 52-week high at 182.98 USD By Investing.com - Investing.com South Africa
Illumina Inc. focuses on sequencing and clinical genomics as investors watch long term growth - AD HOC NEWS
Piper Sandler raises Illumina stock price target on clinical strength - Investing.com
Why Illumina (ILMN) Stock Is Down Today - Yahoo Finance
Roche takes on Illumina with new NGS system - MedTech Dive
Illumina: The Operational Turnaround Is Fully Priced In (NASDAQ:ILMN) - Seeking Alpha
Illumina earnings outlook and consensus, shares on NASDAQ - AD HOC NEWS
The NextSeq 2000 from Illumina Inc.mid-throughput sequencing aims for everyday lab work - AD HOC NEWS
Illumina Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Roche launches Axelios 1 sequencing platform to rival Illumina - BioWorld News
Roche takes aim at Illumina’s dominance with new gene sequencing machine - WNWN-FM
0.63%
0.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):